DelphX Capital Markets Inc. develops structured-product technology and financial services for broker-dealers. Through its special purpose vehicle Quantem LLC, the company enables private placement securities designed for fixed-income and cryptocurrency-based solutions, including Collateralized Put Options and Collateralized Reference Notes. News about DPXCF commonly covers non-brokered unit private placements, common-share and warrant terms, TSX Venture Exchange-related conditions, stock option grants under its option plan, and updates tied to structured-product distribution.
DelphX (OTCQB: DPXCF) intends a non-brokered private placement of up to 5,000,000 Units at C$0.05 per Unit to raise up to C$250,000 gross. Each Unit includes one common share and one warrant exercisable at C$0.08 for two years. Securities will be subject to a four-month plus one-day hold period and the Offering requires TSX Venture Exchange approval. DelphX may pay finder’s fees and insiders may participate, with net proceeds earmarked for general corporate purposes.
DelphX (OTCQB: DPXCF) intends to seek TSX Venture Exchange approval to extend the exercise period of 3,904,166 share purchase warrants exercisable at $0.20 by one year to January 30, 2027. All other warrant terms remain unchanged and the extension is subject to TSXV acceptance.
A total of 1,208,333 warrants are held by related parties, making the amendment a related party transaction under MI 61-101 and TSXV Policy 5.9, but exemptions for formal valuation and minority approval apply because the warrants' fair market value does not exceed 25% of DelphX market capitalization.
DelphX (OTCQB: DPXCF) closed a non-brokered unit private placement on January 30, 2026, issuing 3,000,000 Units at C$0.05 per Unit for gross proceeds of C$150,000. Each Unit includes one common share and one warrant exercisable at $0.08 for two years.
An insider subscribed for all 3,000,000 Units, making the transaction a related party participation under MI 61-101; DelphX relied on exemptions to formal valuation and minority approval. Closing remains subject to TSX Venture Exchange approval and issued securities carry a four-month-plus-one-day hold. Net proceeds are intended for working capital and corporate overhead.
DelphX (OTCQB: DPXCF, TSXV: DELX) announced a non-brokered private placement of up to 3,000,000 units at C$0.05 per unit for gross proceeds of C$150,000. Each Unit comprises one common share and one warrant exercisable at $0.08 for two years. Completion is subject to TSX Venture Exchange approval and securities will carry a 4-month plus one day hold period. Insiders may participate subject to insider trading policy. Net proceeds are intended for working capital and corporate overhead.
DelphX Capital Markets (OTCQB: DPXCF) announced a non-binding letter of intent with Belgravia Hartford Capital to pursue the first anticipated commercial transaction using DelphX's Quantem Crypto Security (QCS), specifically a QCS-collateralized put option intended to protect corporate Bitcoin treasury holdings. The LOI is non-binding and conditioned on definitive documentation, regulatory approvals, market conditions, and customary closing conditions.
DelphX also announced a CFO transition: Simon Selkrig will return as CFO effective January 1, 2026. The board approved a grant of 2,875,000 stock options, exercisable at $0.08 with a two-year maturity.
DelphX (OTCQB: DPXCF, TSXV: DELX) closed a non-brokered private placement on December 22, 2025, issuing 1,250,000 units at C$0.04 per unit for gross proceeds of C$50,000. Each unit includes one common share and one warrant.
Each warrant is exercisable for one common share at $0.06 for two years from issuance. Completion is subject to TSX Venture Exchange approval. Securities are subject to a four-month plus one day hold period. DelphX intends to use net proceeds for working capital and corporate overhead.
DelphX (OTCQB: DPXCF) announced a non-brokered private placement of 1,250,000 units at C$0.04 per unit for gross proceeds of C$50,000. Each unit includes one common share and one warrant; each warrant is exercisable for one common share at $0.06 for two years from issuance. Completion is subject to TSX Venture Exchange approval and issued securities will be subject to a four-month plus one day hold period. DelphX intends to use net proceeds for working capital and corporate overhead.
DelphX (OTCQB: DPXCF; TSXV: DELX) closed a non-brokered unit private placement announced Nov 27, 2025, issuing 2,800,000 units at C$0.04 per unit for gross proceeds of C$112,000. Each unit comprises one common share and one warrant.
Each warrant allows purchase of one common share at $0.07 for two years from issuance. Completion remains subject to TSX Venture Exchange approval. Securities are subject to a four-month plus one day hold period. DelphX intends to use net proceeds for working capital and corporate overhead.
DelphX (OTCQB: DPXCF) announced a non-brokered private placement of 2,800,000 units at C$0.04 per unit for gross proceeds of C$112,000. Each unit includes one common share and one warrant exercisable at $0.07 for two years. Closing is subject to TSX Venture Exchange approval and a four-month-and-one-day hold period on securities. Net proceeds are intended for general corporate purposes.
DelphX also seeks TSXV approval to extend the exercise period of 5,422,221 warrants (exercise price $0.15) by one year to December 7, 2026. 1,611,111 of those warrants are held by related parties; the company says available exemptions under MI 61-101 apply.
DelphX (OTCQB: DPXCF) provided a shareholder update on its Quantem Crypto Securities (QCS) fully‑collateralized hedging solution on November 18, 2025. Since QCS marketing began in mid‑September 2025, Bitcoin moved from above US$115,000 to below US$90,000, highlighting demand for institutional hedges. QCS is described as fully collateralized, transparent, and structured to mitigate volatility and protect treasury assets.
The company says a U.S. primary dealer is evaluating a possible proof‑of‑concept and multiple digital‑asset treasuries are conducting due diligence and scenario testing, but implementation is not assured.